搜尋
Vaxart Inc
VXRT添加自選
0.320USD
0.0000.00%
交易中 （美東）報價延遲15分鐘
73.03M總市值
虧損本益比TTM
關於 Vaxart Inc 公司
Vaxart, Inc. 是一家臨牀階段的生物技術公司，主要專注於基於其載體佐劑抗原標準化技術 (VAAST) 專有口服疫苗平臺開發口服重組疫苗。其疫苗設計爲使用藥丸給藥，可在無需冷藏的情況下儲存和運輸，並消除針刺傷的風險。其開發計劃包括旨在預防諾如病毒（急性胃腸炎的病因）、冠狀病毒（包括 SARS-CoV-2 (COVID-19)）和流感的藥丸疫苗。此外，該公司還爲其針對宮頸癌和人乳頭瘤病毒引起的發育不良的治療性疫苗候選物生成了臨牀前數據。該公司的平臺技術採用基於載體的方法，由各種組件組成，例如載體（腺病毒 5 型 (Ad5)；抗原 (Ad5 DNA)；佐劑（Toll 樣受體 3 (TLR3)）和其專有的腸溶片。
Vaxart Inc簡介
公司代碼VXRT
公司名稱Vaxart Inc
上市日期Mar 17, 1980
CEOMr. Steven (Steve) Lo
員工數量105
證券類型Ordinary Share
年結日Mar 17
公司地址170 Harbor Way, Suite 300
城市SOUTH SAN FRANCISCO
上市交易所US 'Other OTC' and Grey Market
國家United States of America
郵編94080
電話16505503500
網址https://vaxart.com/
公司代碼VXRT
上市日期Mar 17, 1980
CEOMr. Steven (Steve) Lo
Vaxart Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Edward B. Berg
Mr. Edward B. Berg
Senior Vice President, General Counsel
Senior Vice President, General Counsel
435.74K
+0.24%
Mr. Jeroen Grasman
Mr. Jeroen Grasman
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
350.00K
--
Mr. Steven (Steve) Lo
Mr. Steven (Steve) Lo
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
237.34K
+0.03%
Dr. Elaine J. Heron, Ph.D.
Dr. Elaine J. Heron, Ph.D.
Independent Director
Independent Director
80.57K
+0.12%
Dr. Sean N. Tucker, Ph.D.
Dr. Sean N. Tucker, Ph.D.
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Mr. W. Mark Watson
Mr. W. Mark Watson
Lead Independent Director
Lead Independent Director
--
--
Dr. James F. Cummings, M.D.
Dr. James F. Cummings, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Kevin P. Finney
Mr. Kevin P. Finney
Independent Director
Independent Director
--
--
Mr. Matt Stein
Mr. Matt Stein
IR Contact Officer
IR Contact Officer
--
--
Ms. Laurie Hastings
Ms. Laurie Hastings
Senior Vice President of Human Resources
Senior Vice President of Human Resources
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Edward B. Berg
Mr. Edward B. Berg
Senior Vice President, General Counsel
Senior Vice President, General Counsel
435.74K
+0.24%
Mr. Jeroen Grasman
Mr. Jeroen Grasman
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
350.00K
--
Mr. Steven (Steve) Lo
Mr. Steven (Steve) Lo
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
237.34K
+0.03%
Dr. Elaine J. Heron, Ph.D.
Dr. Elaine J. Heron, Ph.D.
Independent Director
Independent Director
80.57K
+0.12%
Dr. Sean N. Tucker, Ph.D.
Dr. Sean N. Tucker, Ph.D.
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Mr. W. Mark Watson
Mr. W. Mark Watson
Lead Independent Director
Lead Independent Director
--
--
常見問題
Vaxart Inc的前五大股東是誰？
Vaxart Inc的前五大股東如下：Mr. Edward B. Berg
有多少機構持有Vaxart Inc(VXRT)的股份？
截至2026Q1，共有188家機構持有Vaxart Inc的股份，合計持有的股份價值約為120.77K，占公司總股份的0.05% 。與2025Q4相比，機構持股有所增加，增幅為-50563267.00。
